Published April 2021 | Version v1
Journal article

Molecular dynamics insights into binding selectivity of inhibitors toward BRD4 and CBP

  • 1. School of Science, Shandong Jiaotong University, Jinan, 250357 (China)

Description

Highlights: • Cross-correlation analysis reveals significant effect of inhibitor bindings on conformations of BRD4 and CBP. • MM-GBSA calculations uncover that inhibitors produce stronger bindings to CBP than BRD4. • Residue-based free energy decomposition detects hot spots of inhibitor bindings to BRD4 and CBP. Molecular dynamics (MD) simulations and binding free energy calculations were run to explore binding selectivity of inhibitors F3J, EX1, and E2T toward bromodomain-containing protein 4 (BRD4) and CREB binding protein (CBP). Dynamics analysis reveals dependence of binding selectivity on conformational changes and movement modes of BRD4 and CBP. Meanwhile, estimations of residue-based free energy decomposition not only recognize hot spots of inhibitor bindings to two proteins but also reveal that residues Trp81/Leu1109, Pro82/Pro1110, Gln85/Gln1113, Val87/Val1115, Leu92/Leu1120, Leu94/Ile1122, Asn140/Asn1168, and Ile146/Val1174 in BRD4/CBP generate obvious binding difference, which is responsible for binding selectivity of inhibitors toward BRD4 and CBP.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.cplett.2021.138435

Additional details

Identifiers

DOI
10.1016/j.cplett.2021.138435;
PII
S0009261421001184;

Publishing Information

Journal Title
Chemical Physics Letters
Journal Volume
769
Journal Page Range
vp.
ISSN
0009-2614
CODEN
CHPLBC

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54027048
Subject category
S74: ATOMIC AND MOLECULAR PHYSICS;
Descriptors DEI
COMPUTERIZED SIMULATION; CONFORMATIONAL CHANGES; FREE ENERGY; HOT SPOTS; MOLECULAR DYNAMICS METHOD
Descriptors DEC
CALCULATION METHODS; ENERGY; PHYSICAL PROPERTIES; SIMULATION; THERMODYNAMIC PROPERTIES

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.